Large Cap Biopharmaceuticals: Performance Metrics-January 2026: Growth plus Dividends
Large Cap Biopharmaceuticals -Core Positions for Any Healthcare Portfolio The IBB Large cap weighted Biotech ETF beats the S&P 500 (SPY) with a 25% Return. A portfolio with 3-4 with our Large Cap picks did better: ABBV ,GILD, LLY. Or one fund FBIOX up about 28% YTD. Provide growth plus...
Health Science Stocks: Recent Picks and Year End Trading…green screen day alert!.. Update-3 January Five.
1/5/26..A red screen day in biotech and biopharma : SMID caps brought two ETFS down about 1% but damage in SMIDs was contained off the lows. some stocks we own were actually up over 2%: CYRX up 2.82%,TEM up 3.75%, TMO up 3.15%,PSNL up 2.16%,QDEL up 4.44% ...etc. But many large caps were down...
Top Down Review of Healthcare and Biotech Stocks: Growth Opportunities in Biopharma and Genomics….Updates 12/20
Update-3 12/20/25....A recovery week for biotech with XBI up 0.24% at $123.43 after being down to the $119 level,, IBB u p0.46% at $170.20 after being down to $165,76. Many stocks were up big on Friday' as the WH might be finished with DRUG PRICE negotiations.Some tariff breaks have been given...
Traders and Investors are Winning with Biotech Stocks…Update-1
Update-1 12/13/25..Biotechs hold for the week as rotation moves out of Tech stocks; The IBB is down 0.51% but up 28% YTD at $169.42; XBI is down o.23% up 36.7% YTD at $123; ARKG down 2.36%, up 27.37% YTD at $30.20. Small cap performance also bodes well for SMID biotechs with IWM up 3% MTD. The...
Biotech Stocks Cruise to New Highs While Boosting Healthcare Sector…Update-3 DEC 5…alert
Update-3 12/5/25...3:15 PST...EYPT still strong up another 5%;.ADPT down another big 14%-Benziga has a note on a Natera buyout that must be related to drop in ADPT stock. More later but more competition is coming to blood cancers so watch ASH-American Society for Hematology coming up this...